share_log

Philip Morris International | 8-K: Philip Morris Reaffirms 2024 Earnings Forecast

Philip Morris International | 8-K: Philip Morris Reaffirms 2024 Earnings Forecast

菲利普莫里斯 | 8-K:菲利普莫里斯重申2024年收益预测
美股SEC公告 ·  2024/09/03 19:06

Moomoo AI 已提取核心信息

Philip Morris International (PMI) has reaffirmed its 2024 full-year reported diluted EPS forecast of $5.89 to $6.01, with adjusted diluted EPS projected at $6.33 to $6.45. Excluding adjustments of $0.44 per share and currency impact of $0.34 per share, this represents an 11-13% currency-neutral growth compared to 2023's adjusted EPS of $6.01.PMI's CEO Jacek Olczak will participate in a fireside chat at the 2024 Barclays Global Consumer Staples Conference on September 3, 2024. The company's smoke-free products are now available in 90 markets, with approximately 38% of first-half 2024 net revenues coming from smoke-free business. PMI estimates 36.5 million adults globally use their smoke-free products.The company has invested over $12.5 billion since 2008 in developing smoke-free products, including the acquisition of Swedish Match. PMI's portfolio expansion includes the IQOS and ZYN brands, with both companies' products receiving Modified Risk Tobacco Products authorization from the FDA, though renewal applications are pending.
Philip Morris International (PMI) has reaffirmed its 2024 full-year reported diluted EPS forecast of $5.89 to $6.01, with adjusted diluted EPS projected at $6.33 to $6.45. Excluding adjustments of $0.44 per share and currency impact of $0.34 per share, this represents an 11-13% currency-neutral growth compared to 2023's adjusted EPS of $6.01.PMI's CEO Jacek Olczak will participate in a fireside chat at the 2024 Barclays Global Consumer Staples Conference on September 3, 2024. The company's smoke-free products are now available in 90 markets, with approximately 38% of first-half 2024 net revenues coming from smoke-free business. PMI estimates 36.5 million adults globally use their smoke-free products.The company has invested over $12.5 billion since 2008 in developing smoke-free products, including the acquisition of Swedish Match. PMI's portfolio expansion includes the IQOS and ZYN brands, with both companies' products receiving Modified Risk Tobacco Products authorization from the FDA, though renewal applications are pending.
菲利普莫里斯(PMI)重申其2024年全年的报告摊薄后每股收益预测为5.89美元至6.01美元,调整后的摊薄后每股收益预计为6.33美元至6.45美元。排除每股调整0.44美元和每股货币影响0.34美元,这相比2023年的调整后每股收益6.01美元,代表了11-13%的中立货币增长。PMI的首席执行官Jacek Olczak将于2024年9月3日在2024年巴克莱银行全球消费品大会上参与一个炉边谈话。该公司的无烟产品目前在90个市场可用,预计2024年上半年约38%的净收入来自无烟业务。PMI估计全球有3650万成年人使用他们的无烟产品。自2008年以来,该公司在开发无烟产品方面投资超过125亿美元,包括收购瑞典Match。PMI的产品组合扩展包括IQOS和ZYN品牌,两家公司均获得FDA的修改风险烟草制品授权,但续期申请仍待处理。
菲利普莫里斯(PMI)重申其2024年全年的报告摊薄后每股收益预测为5.89美元至6.01美元,调整后的摊薄后每股收益预计为6.33美元至6.45美元。排除每股调整0.44美元和每股货币影响0.34美元,这相比2023年的调整后每股收益6.01美元,代表了11-13%的中立货币增长。PMI的首席执行官Jacek Olczak将于2024年9月3日在2024年巴克莱银行全球消费品大会上参与一个炉边谈话。该公司的无烟产品目前在90个市场可用,预计2024年上半年约38%的净收入来自无烟业务。PMI估计全球有3650万成年人使用他们的无烟产品。自2008年以来,该公司在开发无烟产品方面投资超过125亿美元,包括收购瑞典Match。PMI的产品组合扩展包括IQOS和ZYN品牌,两家公司均获得FDA的修改风险烟草制品授权,但续期申请仍待处理。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息